Free Trial
NYSEAMERICAN:PHGE

BiomX (PHGE) Stock Price, News & Analysis

BiomX logo
$0.41 -0.01 (-2.38%)
As of 04:10 PM Eastern

About BiomX Stock (NYSEAMERICAN:PHGE)

Key Stats

Today's Range
$0.40
$0.43
50-Day Range
$0.39
$0.59
52-Week Range
$0.34
$3.59
Volume
248,895 shs
Average Volume
134,834 shs
Market Capitalization
$10.73 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$15.00
Consensus Rating
Buy

Company Overview

BiomX Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
46th Percentile Overall Score

PHGE MarketRank™: 

BiomX scored higher than 46% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    BiomX has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    BiomX has only been the subject of 1 research reports in the past 90 days.

  • Read more about BiomX's stock forecast and price target.
  • Earnings Growth

    Earnings for BiomX are expected to decrease in the coming year, from ($2.77) to ($2.92) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of BiomX is -0.48, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of BiomX is -0.48, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    BiomX has a P/B Ratio of 1.37. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about BiomX's valuation and earnings.
  • Percentage of Shares Shorted

    2.15% of the float of BiomX has been sold short.
  • Short Interest Ratio / Days to Cover

    BiomX has a short interest ratio ("days to cover") of 1.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in BiomX has recently increased by 137.49%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    BiomX does not currently pay a dividend.

  • Dividend Growth

    BiomX does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    2.15% of the float of BiomX has been sold short.
  • Short Interest Ratio / Days to Cover

    BiomX has a short interest ratio ("days to cover") of 1.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in BiomX has recently increased by 137.49%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    BiomX has a news sentiment score of 0.87. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.56 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for BiomX this week, compared to 0 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, BiomX insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 1.17% of the stock of BiomX is held by insiders.

  • Percentage Held by Institutions

    40.57% of the stock of BiomX is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about BiomX's insider trading history.
Receive PHGE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BiomX and its competitors with MarketBeat's FREE daily newsletter.

PHGE Stock News Headlines

BiomX Publishes Promising Phase 1b/2a Trial Results
Trump’s treachery
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
BiomX Inc.
BiomX reports ‘positive’ results from 2 trial evaluating BX211
See More Headlines

PHGE Stock Analysis - Frequently Asked Questions

BiomX's stock was trading at $0.5870 at the start of the year. Since then, PHGE shares have decreased by 30.2% and is now trading at $0.41.

BiomX Inc. (NYSEAMERICAN:PHGE) released its quarterly earnings results on Tuesday, November, 14th. The company reported ($0.13) EPS for the quarter, missing analysts' consensus estimates of ($0.10) by $0.03.

Shares of PHGE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that BiomX investors own include Moderna (MRNA), T2 Biosystems (TTOO), Chegg (CHGG), Aldeyra Therapeutics (ALDX), Nokia (NOK), Avino Silver & Gold Mines (ASM) and Anavex Life Sciences (AVXL).

Company Calendar

Last Earnings
11/14/2023
Today
7/10/2025
Next Earnings (Estimated)
8/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSEAMERICAN
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Pharmaceutical Products
Current Symbol
NYSEAMERICAN:PHGE
CIK
1739174
Fax
N/A
Employees
120
Year Founded
N/A

Price Target and Rating

High Price Target
$15.00
Low Price Target
$15.00
Potential Upside/Downside
+3,558.5%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$17.73 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$0.30 per share
Price / Book
1.37

Miscellaneous

Free Float
25,870,000
Market Cap
$10.73 million
Optionable
N/A
Beta
1.41
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NYSEAMERICAN:PHGE) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners